Publication | Open Access
Weekly high‐dose calcitriol and docetaxel in patients with metastatic hormone‐refractory prostate cancer previously exposed to docetaxel
29
Citations
21
References
2007
Year
Weekly high-dose calcitriol and docetaxel seems to be an effective and well-tolerated treatment option for patients with metastatic HRPC previously exposed to docetaxel-based chemotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1